Viatris Inc. 心血管疾病创新产品组合扩容:首次推出心力衰竭治疗药物Inpefa®(Sotagliflozin)

美股速递
Jan 20

Viatris Inc. 正在通过其首次推出的心力衰竭治疗药物Inpefa®(Sotagliflozin),扩大其在心血管疾病领域的创新产品组合。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10